William Lis

2013 - Portola Pharmaceuticals

In 2013, William Lis earned a total compensation of $1.4M as Chief Executive Officer at Portola Pharmaceuticals, a 27% decrease compared to previous year.

Compensation breakdown

Bonus$150,000
Non-Equity Incentive Plan$216,750
Option Awards$613,692
Salary$425,000
Other$500
Total$1,405,942

Lis received $613.7K in option awards, accounting for 44% of the total pay in 2013.

Lis also received $150K in bonus, $216.8K in non-equity incentive plan, $425K in salary and $500 in other compensation.

Rankings

In 2013, William Lis' compensation ranked 5,191st out of 12,286 executives tracked by ExecPay. In other words, Lis earned more than 57.7% of executives.

ClassificationRankingPercentile
All
5,191
out of 12,286
58th
Division
Manufacturing
1,794
out of 4,614
61st
Major group
Chemicals And Allied Products
517
out of 1,466
65th
Industry group
Drugs
368
out of 1,160
68th
Industry
Pharmaceutical Preparations
294
out of 890
67th
Source: SEC filing on April 30, 2015.

Lis' colleagues

We found two more compensation records of executives who worked with William Lis at Portola Pharmaceuticals in 2013.

2013

Mardi Dier

Portola Pharmaceuticals

Chief Financial Officer

2013

John Curnutte

Portola Pharmaceuticals

Executive Vice President, Research and Development

News

You may also like